In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Agilon Health Inc (NYSE: AGL) was $2.12 for the day, down -2.30% from the previous closing price of $2.17. In other words, the price has decreased by -$2.30 from its previous closing price. On the day, 3.07 million shares were traded. AGL stock price reached its highest trading level at $2.17 during the session, while it also had its lowest trading level at $2.1.
Ratios:
Our analysis of AGL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.20. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.01.
On April 08, 2025, Bernstein Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $8.50.
Citigroup Upgraded its Sell to Neutral on January 10, 2025, whereas the target price for the stock was revised from $1.75 to $2.25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 13 ’24 when McLoughlin Karen bought 25,000 shares for $2.20 per share. The transaction valued at 55,085 led to the insider holds 73,166 shares of the business.
Battaglia Silvana bought 25,062 shares of AGL for $50,269 on Dec 11 ’24. The Director now owns 66,144 shares after completing the transaction at $2.01 per share. On Nov 25 ’24, another insider, MCKENZIE DIANA, who serves as the Director of the company, bought 12,500 shares for $2.28 each. As a result, the insider paid 28,474 and bolstered with 51,319 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGL now has a Market Capitalization of 877578176 and an Enterprise Value of 627024064. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.15 while its Price-to-Book (P/B) ratio in mrq is 1.75. Its current Enterprise Value per Revenue stands at 0.105 whereas that against EBITDA is -2.278.
Stock Price History:
The Beta on a monthly basis for AGL is 0.16, which has changed by -0.69714284 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, AGL has reached a high of $7.62, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is -9.63%, while the 200-Day Moving Average is calculated to be -28.87%.
Shares Statistics:
AGL traded an average of 4.23M shares per day over the past three months and 2420730 shares per day over the past ten days. A total of 413.02M shares are outstanding, with a floating share count of 303.70M. Insiders hold about 26.63% of the company’s shares, while institutions hold 73.52% stake in the company. Shares short for AGL as of 1749772800 were 21228626 with a Short Ratio of 4.93, compared to 1747267200 on 22198808. Therefore, it implies a Short% of Shares Outstanding of 21228626 and a Short% of Float of 8.3900005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
